Skip to main content

UBS Group AG

Position in ABUS — Arbutus Biopharma Corp

CIK 1610520 ZURICH, V8

Position in ABUS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,196,198
-$443,920 QoQ
Shares Held
249,208
-31.6% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 175 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in ABUS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,364,122 across 562 Biotechnology names. ABUS ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABUS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,196,198 249,208
2026-03-31 $1,640,118 364,471
2025-12-31 $708,473 147,292
2025-09-30 $3,516,656 774,594
2025-06-30 $587,742 190,208
2025-03-31 $671,099 192,292
2024-12-31 $330,286 101,005
2024-09-30 $648,239 168,374
2024-06-30 $172,003 55,665
2024-03-31 $347,842 134,823
2023-12-31 $349,927 139,971
2023-09-30 $127,114 62,618
2023-06-30 $156,784 68,167
2023-03-31 $111,094 36,665
2022-12-31 $54,263 23,289
2022-03-31 $3,868 1,298
2021-12-31 $132,679 34,108
2021-06-30 $188,799 62,310
2021-03-31 $243,472 73,115
2020-12-31 $63,637 17,926
2020-09-30 $21,950 7,013
2020-06-30 $590,211 324,292
2020-03-31 $373,849 370,148